CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,230,845
- in 7 filings, $1.6M under 10b5-1 plans
Net −$2,230,845. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 37 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-11 | Ballal Rahul D. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −48,820 | 0 | ||
| 2024-04-11 | Ballal Rahul D. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −4,580 | 75,742 | ||
| 2024-04-10 | Ballal Rahul D. Director | Option exercise 10b5-1 | +13,600 | $12.60 | $171K | 35,941 |
| 2024-04-10 | Ballal Rahul D. Director | Sale 10b5-1 | −13,600 | $21.01 | $286K | 22,341 |
| 2024-04-10 | Ballal Rahul D. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −13,600 | 48,820 | ||
| 2024-04-08 | Kunkel Lori Anne Director | Grant or award · Stock Option (right to buy) | +37,882 | 37,882 | ||
| 2024-04-08 | Patel Anish CHIEF OPERATING OFFICER | Sale 10b5-1 | −4,331 | $18.50 | $80K | 3,141 |
| 2024-04-08 | Patel Anish CHIEF OPERATING OFFICER | Sale 10b5-1 | −544 | $19.40 | $11K | 2,597 |
| 2024-04-04 | Ballal Rahul D. Director | Option exercise 10b5-1 | +3,485 | $12.60 | $44K | 25,826 |
| 2024-04-04 | Ballal Rahul D. Director | Sale 10b5-1 | −3,485 | $19.15 | $67K | 22,341 |
| 2024-04-04 | Ballal Rahul D. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −3,485 | 62,420 | ||
| 2024-04-01 | Ballal Rahul D. Director | Option exercise 10b5-1 | +94 | $12.60 | $1K | 22,435 |
| 2024-04-01 | Ballal Rahul D. Director | Option exercise 10b5-1 | +3,143 | $5.52 | $17K | 25,578 |
| 2024-04-01 | Ballal Rahul D. Director | Sale 10b5-1 | −3,237 | $19.08 | $62K | 22,341 |
| 2024-04-01 | Ballal Rahul D. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −94 | 65,905 | ||
| 2024-04-01 | Ballal Rahul D. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −3,143 | 16,428 | ||
| 2024-04-01 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +12,000 | $1.12 | $13K | 12,000 |
| 2024-04-01 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale 10b5-1 | −2,352 | $17.72 | $42K | 9,648 |
| 2024-04-01 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale 10b5-1 | −9,577 | $18.80 | $180K | 71 |
| 2024-04-01 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale 10b5-1 | −71 | $19.36 | $1K | 0 |
Page 23 of 37 · 724 trades